Skip to Content

CL 301 (Efavirenz 600 mg)

Pill with imprint CL 301 is Yellow, Capsule-shape and has been identified as Efavirenz 600 mg. It is supplied by Cipla USA Inc..

Efavirenz is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 301

Efavirenz 600 mg CL 301

Efavirenz

Imprint
CL 301
Strength
600 mg
Color
Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
NNRTIs
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0301
Inactive Ingredients
lactose monohydrate, croscarmellose sodium, povidone k30, calcium phosphate dibasic anhydrous, magnesium stearate, titanium dioxide, ferric oxide yellow, polyethylene glycol 400, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.